This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Collette L, Mauer M, BOLLA M, van Tienhoven G, de Reijke TM, Van Den Bergh ACM, Oddens J, Poortmans PMP, Bottomley A, EORTC Radiation Oncology and Genito-Urinary Tract Cancer Groups, EORTC Quality of Life Department.Health related quality of life and symptoms in an international phase III trial of long term versus short-term androgen suppression and radiation therapy for locally advanced prostate cancer (EORTC Trial 22961). 24th Annual Congress of the European Association of Urology: 307 abstr. 745, 20 Mar 2009
Rights and permissions
About this article
Cite this article
Long-term androgen suppression impact on QOL “acceptable”. Pharmacoecon. Outcomes News 579, 13 (2009). https://doi.org/10.2165/00151234-200905790-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00029